Lab-on-a-chip technologies for diagnosis and monitoring of airway inflammation

Abstract

From the Department of Electrical and Computer Engineering, Rutgers University. Disclosure of potential conflict of interest: M. Javanmard has a patent pending for ''Quantification of Inflammatory Molecules in Exhaled Breath Condensate Using Differential Pulse Voltammetry on Reduced Graphene Oxide Sensor'' and a patent issued for ''Microfluidic Method for Measurement or Detection Involving Cells or Biomolecules.''

Micro thermoelectric devices: From principles to innovative applications

“…Microfluidic chip, also called lab-on-the-chip, is a technology to control the microliter or nanoliter liquid in the micrometer channel structure, [116][117][118] which can flexibly combine multiple unit technologies in the system to form a network structure to achieve chip-scale integration, shorten sample processing time, significantly improve measurement resolution and sensitivity, thus greatly reducing consumption and cost. [119] Microfluidic chip technology has been widely used in clinical testing, [120] point of care, [121] micro reaction and flow chemistry, [122] cell growth, [123] high throughput drug screening, [124] and other fields. According to the data statistics from Yole analysts in 2019, [125] the global market size of microfluidic products reached 8.7 billion US dollars in 2018, with a compound annual growth rate of 11.7% between 2019 and 2024, and it is expected to reach 17.4 billion US dollars in 2024.…”